ALTONA DIAGNOSTICS GMBH

Company Overview

A medical diagnostic company, Altona Diagnostics, develops in vitrodiagnostic tests for the PCR-based identification of pathogens like bacteria, viruses and parasites. Privately held, Altona Diagnostics has its headquarters in Hamburg-Altona, Germany and employs over 350 people globally. The business is ISO 13485 accredited and has operated in the molecular diagnostics industry for more than 20 years. Via subsidiaries and more than 40 distribution partners, Altona Diagnostics distributes its registered products to private and clinical laboratories throughout the world. Based on real-time PCR technology, Altona Diagnostics’ molecular diagnostic tests come in kits that are ready to use. There are more than fifty CE-marked kits that work with open real-time PCR platforms in the company’s product portfolio. Furthermore, Altona Diagnostics provides an automated workflow solution that includes specialized software, instruments and nucleic acid extraction chemicals.

In 1998, artus Diagnostics, a spin-off from Bernhard-Nocht-Institute for Tropical Medicine in Hamburg, Germany, was started and in 2005, Artus was acquired by Qiagen and in 2011, Artus Diagnostics was renamed Altona Diagnostics.

Company's Business Segments

• Medical Diagnostic : This segment develops and manufactures 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 diagnostic tests for the PCR based detection of pathogens such as viruses, bacteria or parasites.